Dr. Duane Mitchell and his team received funding to bolster clinical research programs advancing novel immunotherapy treatments.
Dr. Duane Mitchell named CTSI director, will lead UF’s efforts to move research discoveries to patients.
In the latest edition of Florida Physician, read how UF brings together the world’s leading experts to help rewrite the story of brain cancer.
Dr. Catherine Flores will expand her research into a new use of stem cells to enhance the clinical effectiveness of adoptive T cell therapy against brain tumors.
See media highlights stemming from Feb. 22's announcement of The Harris Rosen Foundation's gift to advance brain tumor immunotherapy research at the MBI and launch the ReMission Alliance Against Brain Tumors.